Alpha-adrenergic approach in the medical management of benign prostatic hyperplasia.
Mátyus
P
P
Semmelweis University of Medicine, Institute of Organic Chemistry, Budapest, Hungary.
Horváth
K
K
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000818:Animals; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000648:ultrastructure*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011942:Receptors, Adrenergic, alpha / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D013329:Structure-Activity Relationship
D000317:Adrenergic alpha-Antagonists; D011942:Receptors, Adrenergic, alpha